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Optic Disc Edema, Globe Flattening,
Choroidal Folds, and Hyperopic Shifts
Observed in Astronauts after Long-duration
Space Flight
Thomas H. Mader, MD,1 C. Robert Gibson, OD,2 Anastas F. Pass, OD, JD,3 Larry A. Kramer, MD,4
Andrew G. Lee, MD,5 Jennifer Fogarty, PhD,6 William J. Tarver, MD,6 Joseph P. Dervay, MD,6
Douglas R. Hamilton, MD, PhD,7 Ashot Sargsyan, MD,7 John L. Phillips, PhD,8 Duc Tran, DO,2
William Lipsky, MD,2 Jung Choi, OD,2 Claudia Stern, MD, PhD,9 Raffi Kuyumjian, MD,10
James D. Polk, DO6
Purpose: To describe the history, clinical findings, and possible etiologies of ophthalmic findings discovered
in 7 astronauts after long-duration space flight, and document vision changes in approximately 300 additional
astronauts.
Design: Retrospective, observational examination of ophthalmic findings in 7 astronauts and analysis of
postflight questionnaires regarding in-flight vision changes in approximately 300 additional astronauts.
Participants: Seven astronauts with ophthalmic anomalies upon return from long-duration space missions
to the International Space Station and 300 additional astronauts who completed postflight questionnaires
regarding in-flight vision changes.
Methods: Before and after long-duration space flight, all 7 subjects underwent complete eye examinations,
including cycloplegic and/or manifest refraction and fundus photography. Six underwent postmission optical
coherence tomography (OCT) and magnetic resonance imaging (MRI); 4 had lumbar punctures (LP). Approximately 300 astronauts were queried regarding visual changes during space missions.
Main Outcome Measures: Refractive change, fundus photograph examination, retina OCT, orbital MRI, LP
opening pressures, and examination of visual acuity data.
Results: After 6 months of space flight, 7 astronauts had ophthalmic findings, consisting of disc edema in
5, globe flattening in 5, choroidal folds in 5, cotton wool spots (CWS) in 3, nerve fiber layer thickening by OCT
in 6, and decreased near vision in 6 astronauts. Five of 7 with near vision complaints had a hyperopic
shift ⱖ⫹0.50 diopters (D) between pre/postmission spherical equivalent refraction in 1 or both eyes (range, ⫹0.50
to ⫹1.75 D). These 5 showed globe flattening on MRI. Lumbar punctures performed in the 4 with disc edema
documented opening pressures of 22, 21, 28, and 28.5 cm H2O performed 60, 19, 12, and 57 days postmission,
respectively. The 300 postflight questionnaires documented that approximately 29% and 60% of astronauts on
short and long-duration missions, respectively, experienced a degradation in distant and near visual acuity.
Some of these vision changes remain unresolved years after flight.
Conclusions: We hypothesize that the optic nerve and ocular changes we describe may result from
cephalad fluid shifts brought about by prolonged microgravity exposure. The findings we report may represent
parts of a spectrum of ocular and cerebral responses to extended microgravity exposure.
Financial Disclosure(s): The authors have no proprietary or commercial interest in any of the materials
discussed in this article. Ophthalmology 2011;118:2058 –2069 © 2011 by the American Academy of Ophthalmology.

Physiologic and pathologic changes associated with the
microgravity environment have been studied extensively.
However, the effect of this environment on the eye and
brain is largely unknown. Over the last several years, the
National Aeronautics and Space Administration’s (NASA)
Space Medicine Division has documented astronauts presenting with varying degrees of disc edema, globe flattening, choroidal folds, and hyperopic shifts after long-duration
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space flight. The similarities of the setting and clinical
features of these patients suggests a common etiology inherent to the microgravity environment. Because of the
paucity of in-flight data, the specific cause of these disorders
remains obscure. The authors propose that these findings
may represent manifestations of a pathologic process related
to ocular, optic nerve (ON), or perhaps intracranial cephalad
fluid shifts experienced during microgravity exposure. To
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our knowledge, this is the first published report documenting ophthalmic anomalies in astronauts or cosmonauts during or after space flight.

Subjects and Methods
A postflight survey of approximately 300 astronauts, some of
whom were repeat flyers, revealed that vision changes were commonly observed during and after long-duration space missions.
Since 1989, as part of the postflight eye examination, astronauts
were queried as to whether they perceived a subjective improvement or degradation in distant or near vision (none, mild, moderate, or severe) during their short- and long-duration missions.
Prompted by persistent reports of vision changes, NASA began a
stepwise operational process to determine the etiology. Several
ophthalmic procedures were initiated on astronauts, including dilated fundus examinations with binocular ophthalmoscopy, cycloplegic refraction, optical coherence tomography (OCT), magnetic
resonance imaging (MRI) of orbits, and fundus photos of astronauts before and after space missions.
Space flight causes bone loss. As a countermeasure, it is recommended that all astronauts take 800 international units (IU) of
vitamin D supplements daily during short- and long-duration space
flights. Unless otherwise stated, the past medical history of all 7
astronauts was negative for systemic hypertension, connective
tissue disorders, iron deficiency, diabetes mellitus, or renal disease.
Again, unless stated otherwise, none of our subjects had ever used
any medication that could produce increased intracranial pressure
(ICP); (e.g., vitamin A, tetracycline, corticosteroids, or nalidixic
acid.)
The NASA Space Medicine Division approves of the use of
this routinely acquired and not attributable data to be used in this
manner. These data are acquired under occupational surveillance
and their use in this article is permitted under governance 10
Health Information Management System.

Results
After approximately 6 months of continuous orbital flight, 7 astronauts (all male; age 50.2⫾4.2 years) were documented to have
findings as summarized in Table 1. Table 2 is a summary of data
from postflight questionnaires completed by approximately 300
astronauts after their short- and long-duration space missions.
Approximately 23% of the short-duration and 48% of the longduration mission astronauts complained of near vision difficulties.

Case Reports
Case 1
This astronaut’s preflight manifest refraction at 90 days before
launch was: right eye, ⫺1.50 sphere and left eye, ⫺2.25
⫺0.25⫻135, with a ⫹1.50 add. He was correctable to 20/20 in
each eye and his dilated eye examination and fundus photos
were normal. The only medication he used was promethazine
for space adaptation syndrome. He noticed a marked decrease in
near visual acuity starting about 6 weeks into the mission that
persisted without progression for the remainder of the flight. At
no time did he report headaches, transient visual obscurations,
pulsatile tinnitus, or diplopia. Carbon dioxide levels were at
normal operating levels ⬍5 mmHg during the entire mission.
Oxygen levels were also normal at 160 to 170 mmHg (21%–

23%), the cabin pressure was steady at 735 to 765 mmHg, and
there were no toxic fume exposures.
Nineteen days after return to Earth, his visual acuity was
correctable to 20/20 in both eyes with a manifest refraction
of ⫺1.25 ⫺ 0.25⫻005 in the right eye and ⫺2.50 ⫺ 0.25⫻160 in
the left, with a ⫹2.00 add. He never at any time experienced losses
in subjective best-corrected visual acuity, stereopsis, or color vision. His fundus examination revealed choroidal folds inferior to
the optic disc (right eye) and a single cotton wool spot (CWS) in
the inferior arcade (right eye; Fig 1, available online at http://
aaojournal.org). The acquired choroidal folds gradually improved,
but were still present in fundus photographs taken 3 years postflight. The left eye examination was normal. There was no documented evidence of optic disc edema in either eye. Brain MRI,
lumbar puncture (LP), and OCT were not performed preflight or
postflight on this astronaut. It should be noted that choroidal folds
are still present (right eye only) on OCT performed ⬎5 years
postflight (Fig 1, bottom).

Case 2
This astronaut’s manifest refraction 120 days before the mission
was ⫹0.75 sphere on the right and ⫹0.75 ⫺0.25⫻165 on the left;
his visual acuity was correctable in each eye to 20/15. He had
a ⫹2.25 bifocal add in both lenses. His dilated fundus examination
was normal and documented with preflight fundus photos. During
the mission, he took a multivitamin daily, potassium citrate (part of
an experiment), and zolpidem occasionally for sleep induction.
During the first 2 months in orbit, he had no visual complaints
and could see the Earth clearly without glasses. Approximately 3
months into the mission, he noted that he could now only see the
Earth clearly while looking through the lower portion of his
progressive reading glasses. This change persisted for the remainder of the mission without noticeable improvement or progression.
He complained of no transient visual obscurations, headaches,
diplopia, pulsatile tinnitus, or vision changes during eye movement. Carbon dioxide, cabin pressure, and oxygen were at normal
operating levels during the mission, and he was not exposed to any
toxic substances.
Upon return to Earth, the vision disturbances observed during
microgravity continued. Twenty-one days after the mission, his
visual acuity was correctable to 20/20 with a manifest refraction
of ⫹2.00 sphere on the right and ⫹2.00 ⫺0.50⫻140 on the left.
Over the next several months, he noted a gradual but incomplete
improvement in vision. His refraction 232 days postflight
was ⫹1.50 sphere on the right and ⫹1.50 ⫺0.25⫻170 on the left.
He never at any time experienced losses in subjective bestcorrected visual acuity, stereopsis, or color vision. Twenty-one
days after his return to Earth, a fundus examination was performed, which documented mild bilateral nasal optic disc edema
(grade 1, Frisén scale), right greater than left, and choroidal folds
(Fig 2, available online at http://aaojournal.org). Fluorescein angiography confirmed the choroidal folds but showed no other
abnormalities. Magnetic resonance angiography and magnetic resonance venogram were normal. The OCT confirmed the increased
nerve fiber layer (NFL) thickening consistent with optic disc
edema nasally and demonstrated a normal macula. An MRI of the
brain and orbits with and without gadolinium contrast, performed
23 days after return, documented mildly dilated ON sheaths and
flattening of the posterior globes bilaterally. A CWS was present in
the left eye 1½ disc diameters inferior temporal to the disc and just
inside the inferior arcades. Two months after return to Earth, a LP
documented a borderline opening pressure of 22 cm H2O with
normal cerebral spinal fluid (CSF) composition.
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Table 1. Neuroophthalmic Changes in Astronauts
ISS
Crew
Member

Mission
Duration
(mos)

1

6

2

6

3

6

4

6

5

6

6

6

7

6

Intraocular Pressure
(mmHg)

Refractive Change

Preflight

Postflight

Fundoscopic Examination
Postflight

Preflight

Postflight

OD: ⫺1.50 sph
OS: ⫺2.25 ⫺ 0.25 ⫻ 135
OD: ⫹0.75 sph
OS: ⫹0.75 ⫺ 0.25 ⫻ 165

OD: ⫺1.25 ⫺ 0.25 ⫻ 005
OS: ⫺2.50 ⫺ 0.25 ⫻ 160
OD: ⫹2.00 sph
OS: ⫹2.00 ⫺ 0.50 ⫻ 140

15 OU

10 OU

14 OU

14 OU

OD: ⫺0.50 sph
OS: ⫺0.25 sph
OD: ⫺0.75 ⫺ 0.50 ⫻ 100
OS: plano ⫺ 0.50 ⫻ 090

OD: Plano
OS: Plano
OD: ⫹0.75 ⫺ 0.50 ⫻ 105
OS: ⫹0.75 ⫺ 0.75 ⫻ 090

10 OU

10 OU

15/13

11/10

OD: ⫺5.75 ⫺ 1.25 ⫻ 010
OS: ⫺5.00 ⫺ 1.50 ⫻ 180
OD: ⫹0.25 sph
OS: ⫹0.25 ⫺ 0.50 ⫻ 152
OD: ⫹1.25 sph
OS: ⫹1.25 sph

OD: ⫺5.00 ⫺ 1.50 ⫻ 015
OS: ⫺4.75 ⫺ 1.75 ⫻ 170
OD: ⫹2.00 ⫺ 0.50 ⫻ 028
OS: ⫹1.00 sph
OD: ⫹2.75 sph
OS: ⫹2.50 sph

14/12

14/12

Normal

14 OU

14 OU

16 OU

12/14

Disc edema OD
Cotton wool spot OS
Disc edema OU
Choroidal folds OD ⬎ OS

Choroidal folds OD
Cotton wool spot OD
Bilateral disc edema OD ⬎ OS
Choroidal folds
OD ⬎ OS
Cotton wool spot OS
Bilateral disc edema OD ⬎ OS
Small hemorrhage OD
Disc edema OD
Choroidal folds OD

CSF ⫽ cerebral spinal fluid; MRI ⫽ magnetic resonance imaging; NFL ⫽ retinal nerve fiber layer; OCT ⫽ optical coherence tomography; OD ⫽ right;
Disc edema was graded with the modified Frisén scale.

Case 3
Preflight cycloplegic refraction was ⫺0.50 sphere in the right eye
and ⫺0.25 sphere in the left eye, and correctable in each eye to
20/15. His dilated eye examination and fundus photos were normal. His past medical history included mild systemic hypertension
controlled with lisinopril (10 mg) and dyslipidemia, wellcontrolled on atorvastatin (10 mg). During the mission, he also
took promethazine for 2 days to treat symptoms of space adaptation syndrome, and a multivitamin (Centrum Silver, Pfizer, New
York, New York), but no additional vitamin A analogs. He reported no changes in visual acuity during the mission with no
complaints of headaches, transient visual obscurations, diplopia, or
pulsatile tinnitus. Carbon dioxide and oxygen levels were at acceptable levels during the mission, and he had no toxic exposures.
No ocular issues were reported by the astronaut at landing.
Three days after return to Earth, he was correctable to 20/20
both eyes with a cycloplegic refraction of plano in each eye.
Fundus examination revealed bilateral, asymmetrical disc edema
(right eye, grade 3; left eye, grade 1; Fig 3). There was no evidence
of choroidal folds or CWS. A small hemorrhage was observed
inferior to the optic disc in the right eye. At 10 days postlanding,
an MRI of the brain and orbits was normal except for ON thickening in the right eye greater than the left eye (Fig 4; available
online at http://aaojournal.org). There was no posterior globe flattening. A magnetic resonance venogram showed no evidence for
cerebral venous sinus thrombosis. On OCT, there was marked
NFL thickening (right eye more than the left eye), consistent with
optic disc edema (Fig 5; available online at http://aaojournal.org.)
At 19 days after return to Earth, an LP documented a mildly
elevated opening pressure of 21 cm H2O with normal CSF
composition.

Case 4
Preflight eye examination revealed a cycloplegic refraction
of ⫺0.75 ⫺ 0.50⫻100 on the right and plano ⫺0.50⫻090 on the
left, correctable in each eye to 20/15. He had a reading add
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of ⫹2.00 both eyes. His preflight dilated eye examination and
fundus photos were normal. During the mission, he used a topical
corticosteroid and oral ketoconazole for a facial rash and promethazine for 1 day to treat symptoms of space adaptation syndrome.
During the mission, this astronaut took a 6-day tapering dose of
methylprednisolone followed by prednisone 40 mg/d for 1 week to
treat an allergic skin condition.
Approximately 6 to 8 weeks into the mission, he reported a
progressive decrease in near visual acuity in his right eye, followed
by a mild, “vertical football”–shaped scotoma located 15° to 30°
into his right temporal field of vision. The scotoma seemed to be
fixed and translucent, and was stable for the remainder of the
mission. He never complained of transient visual obscurations,
headaches, diplopia, pulsatile tinnitus, or vision changes during
eye movement. International Space Station (ISS) cabin pressure,
carbon dioxide, and oxygen levels were reported to be at normal
operating levels during the mission. During the mission, one of his
fellow astronauts also complained of decreased near visual acuity
(case 5). Five months into the mission, a video funduscopic imaging system was used to obtain retinal and ON images that were
downlinked to NASA personnel for ophthalmologic consultation.
These images allowed experts on the ground to diagnose mild
optic disc edema in the right eye (Fig 6). The temporal location and
shape of the reported scotoma was thought to be consistent with
disc edema (i.e., enlarged blind spot).
His vision changes persisted upon return to Earth. Ten days
postflight, his visual acuity was correctable to 20/15 with a cycloplegic refraction of ⫹0.75 ⫺ 0.50⫻105 on the right and to ⫹0.75
⫺ 0.75⫻090 on the left. He never experienced losses in subjective
best-corrected acuity, color vision, or stereopsis. Fundus examination revealed mild, nasal disc edema (grade 1, Frisén scale) of the
right eye with choroidal folds extending from the disc into the
macula (Fig 6). On OCT, optic disc edema and choroidal folds
were confirmed (Fig 7; available online at http://aaojournal.org).
An MRI of the brain and orbits performed 30 days postflight
documented severely dilated ON sheaths (right greater than left),
flattening of the posterior globes (right greater than left), and
thickened tortuous ONs (Fig 8). An intracranial magnetic reso-
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after Long-duration Space Flight

Disc Edema (Frisén)
No disc edema
Grade 1 OD and OS

Grade 3 OD
Grade 1 OS
Grade 1 OD
No disc edema
Grade 1 OD
Grade 1 OD and OS

OCT Postflight
Choroidal folds still visible inferior to
the OD disc (R⫹ ⬎5 yrs)
NFL thickening c/w disc edema

Severe NFL thickening OD ⬎ OS
c/w Disc edema
Mild NFL thickening OD ⬎ OS c/w
disc edema
Choroidal folds OD
Subclinical disc edema
Mild/moderate NFL thickening OD
Mild NFL thickening c/w disc edema
Choroidal folds OD
Moderate NFL thickening c/w disc
edema OD and OS
Choroidal folds OD and OS

Eye MRI Postflight

Globe
Flattening

CSF Pressure
Postflight (cmH2O)

MRI not performed

Not assessed

Not measured

Optic nerve sheath distension
OD and OS

OD and OS

Optic nerve sheath distension
OD
Optic nerve sheath distension
and tortuous optic nerves
OD ⬎ OS
Optic nerve sheath distension
and tortuous optic nerves
Optic nerve sheath distension
OD ⬎ OS
Optic nerve sheath distension
OD and OS

None observed

Elevated
22 at R⫹66 days;
26 at R⫹17 months;
22 at R⫹19 months
Elevated
21 at R⫹19 days
Elevated
28.5 at R⫹57 days

OD ⬎ OS
OD and OS

Not measured

OD ⬎ OS

Not measured

OD and OS

Elevated
28 at R⫹12 days

OS ⫽ left; OU ⫽ both eyes; R⫹ ⫽ return to Earth (eg, R⫹19 is 19 days after return to Earth); sph ⫽ sphere.

nance venogram and magnetic resonance angiography subsequently obtained showed no abnormalities. Fifty-seven days after
return to Earth, an LP documented an elevated opening pressure of
28.5 cm H2O with normal CSF composition.

Case 5
A preflight eye examination revealed a cycloplegic refraction
of ⫺5.75 ⫺ 1.25⫻010 on the right, and ⫺5.00 ⫺ 1.50⫻180 on the
left, correctable in each eye to 20/20. His reading add was ⫹1.75
both eyes. Dilated eye examination and fundus photos were normal. During the mission, he took promethazine for a few days to
treat symptoms of space adaptation syndrome. Three weeks after
launch, he reported a moderate decrease in near visual acuity, right
eye greater than left, which persisted for the remainder of the
mission without change. He never complained of headaches, transient visual obscurations, diplopia, pulsatile tinnitus, or other vision changes. Carbon dioxide, oxygen, and ISS cabin pressure
were at acceptable levels during the mission. One fellow crewmember complained of visual changes (case 4).
Upon return to Earth, he noted persistence of the vision changes
he observed in space. Postflight visual acuity was correctable to
20/20 both eyes with a manifest and cycloplegic refraction
of ⫺5.00 ⫺ 1.50⫻015 on the right and ⫺4.75 ⫺ 1.75⫻170 on the
left and a reading add of ⫹2.25 both eyes. He never experienced
losses in subjective best-corrected acuity, color vision, or stereopsis. His fundus examination was normal with no evidence of disc
edema or choroidal folds. However, MRI of the brain and orbits,
performed 8 days after return, documented bilateral posterior globe
flattening, distended ON sheaths, and tortuous ONs. The ONs
were not thickened. On OCT, significant NFL thickening in the
right eye was shown relative to preflight values and a normal
macula (Fig 9; available online at http://aaojournal.org). An LP
was not performed.

Case 6
Preflight eye examination documented a cycloplegic refraction
of ⫹0.25 sphere on the right and ⫹0.25 ⫺ 0.50⫻152 on the left,

correctable in each eye to 20/15 with a reading add of ⫹1.25. His
dilated eye examination and fundus photos were normal. During
the mission he took promethazine for 1 to 2 days to treat symptoms
of space adaptation syndrome. He reported no significant changes
in visual acuity during the mission and never complained of
transient visual obscurations, diplopia, pulsatile tinnitus, or other
vision changes. Carbon dioxide, oxygen, and cabin pressure levels
were reported to be within acceptable levels throughout the mission. He was not exposed to any toxic substances.
Table 2. Reported In-Flight Subjective Visual Changes and
Postflight Refraction Changes of National Aeronautics and
Space Administration Astronauts (Not Including International
Partners) from 1989 to 2009
Description
Decreased DVA
Total (n)
None
Mild
Moderate
Severe
Decreased NVA
Total (n)
None
Mild
Moderate
Severe
Refraction change
Total (n)
None
Mild
Moderate
Severe

Shuttle % (n)

ISS-Long Duration % (n)

581
93.5 (543)
5.7 (33)
0.9 (5)
0 (0)

44
88.1 (39)
2.4 (1)
4.8 (2)
4.8 (2)

584
76.7 (448)
17.6 (103)
5.5 (32)
0.2 (1)

44
52.3 (23)
13.6 (6)
27.3 (12)
6.8 (3)

587
88.9 (522)
9.2 (54)
1.9 (11)
0 (0)

44
65.9 (29)
25.0 (11)
2.3 (1)
6.8 (3)

DVA ⫽ distance visual acuity; ISS ⫽ International Space Station; NVA ⫽
near visual acuity.
Source: Lifetime Surveillance of Astronaut Health (LSAH) Program,
NASA Johnson Space Center.
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Figure 3. (Top) Preflight images of the right and left optic discs. (Bottom) Postflight images of the right and left optic disc showing grade 3 edema at
the right optic disc and Frisén grade 1 edema at the left optic disc. OD ⫽ right eye; OS ⫽ left eye.

After return to Earth, he noticed that his far vision was clearer
through his reading glasses. Twenty-one days after his return to
Earth, his visual acuity was correctable to 20/20 both eyes with a
cycloplegic refraction of ⫹2.00 ⫺ 0.50⫻028 on the right,
and ⫹1.00 sphere on the left. A fundus examination documented
mild (grade 1) nasal optic disc edema in the right eye only (Fig 10;
available online at http://aaojournal.org). There was no evidence of
disc edema in the left eye. An MRI of the brain and orbits,
performed 46 days after return, revealed bilateral flattening of the
posterior globe, right greater than left, and a mildly distended right
ON sheath. Forty-eight days after return to Earth, his cycloplegic
refraction was ⫹1.50 sphere on the right and ⫹0.75 sphere on the
left. He never experienced losses in subjective best-corrected acuity, color vision, or stereopsis. Fundus examination and OCT
performed at this time documented mild disc edema (right eye,
grade 1) and a CWS in the left eye 2 disc diameters superior
temporal to the disc, just inside the superior arcade. Although
no choroidal folds were visible by ophthalmoscopy in either
eye, mild choroidal folds were noted in the right eye by OCT
(Fig 11; available online at http://aaojournal.org). An LP was
not performed.

Case 7
Preflight cycloplegic refraction was ⫹1.25 sphere both eyes, correctable in each eye to 20/15 with a reading add of ⫹1.75. His
preflight dilated eye examination and fundus photos were normal.
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During the mission, he took promethazine 25 mg by mouth on day
1 of the mission and 12.5 mg on day 2 to treat symptoms of space
adaptation syndrome. While in orbit, he took atorvastatin 40 mg
every day, vitamin D 50 000 IU/month, and 800 mg ibuprofen as
needed. Approximately 2 months into the mission he reported a
progressive decrease in his near and far acuity in both eyes, which
persisted for the remainder of the mission. At approximately 3 to
4 months into the 6-month mission, he noticed that his normal
“Earth” prescription progressive glasses were no longer strong
enough for near tasks at which time he began using his stronger
“Space Anticipation Glasses” (⫹1.25 D more plus). He never
complained of transient visual obscurations, headaches, diplopia,
pulsatile tinnitus, or vision changes during eye movement. The ISS
cabin pressure, carbon dioxide, and oxygen levels were reported to
be at normal operating levels during the mission. He was not
exposed to any toxic substances.
Three days after his return to Earth, his visual acuity was
correctable to 20/20 both eyes with a cycloplegic refraction
of ⫹2.75 sphere on the right, and ⫹2.50 sphere on the left. He
never experienced losses in subjective best-corrected acuity, color
vision, or stereopsis. A fundus examination revealed mild bilateral
optic disc edema (grade 1), and choroidal folds (Fig 12; available
online at http://aaojournal.org; Figs 13 and 14). On OCT, optic
disc edema and chorioretinal folds were confirmed (Fig 15). An
MRI of the brain and orbits performed 6 days postflight documented bilateral flattening of the posterior globes, distended ON
sheaths, and papilledema. Twelve days after return to Earth, LP
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Figure 6. (Top) Preflight images of the right and left posterior pole. (Bottom left) In-flight (International Space Station) photography of the right optic
disc obtained by remote guidance showing a “C” halo associated with Frisén grade 1 edema. (Bottom right) Postflight return to Earth ⫹10 days (R⫹10)
of the right optic disc shows slightly greater degree of edema inferior-nasal. OD ⫽ right eye; OS ⫽ left eye.

documented an elevated opening pressure of 28 cm H2O with
normal CSF composition. A mild degradation in uncorrected near
visual acuity and a mild hyperopic shift was documented on this
astronaut after a previous short-duration Space Shuttle mission
several years before his long-duration mission. His post–Space
Shuttle, short-duration flight eye examination was normal with no
evidence of disc edema or choroidal folds. At that time, MRI and
OCT were not performed postflight. His preflight long-duration
OCT raster scans showed what could be evidence of residual
choroidal folds from his prior short-duration mission (Fig 15).

Discussion
In this report, we have described the development of ophthalmic findings in astronauts after long-duration space
flight. Although the etiology of these findings remains unknown we propose that one of several mechanisms, or a
combination thereof, may best explain our observations.
The first possible explanation is that the findings we describe resulted from increased ICP brought about by prolonged microgravity exposure. Numerous authors have described optic disc edema, globe flattening, choroidal folds,
and a hyperopic shift in a terrestrial environment, which
were thought to be part of the well-defined but still idiopathic syndrome of idiopathic intracranial hypertension

(IIH).1–12 Several reports have described the ultrasonography, OCT, MRI and computed tomography findings in IIH
that include flattening of the posterior globe and enlargement of the subarachnoid space (SAS) around the ON
sheath.3–5,8,10,13 The elevated subarachnoid pressure, caused
by intracranial hypertension, is thought to be directly transmitted from the intracranial compartment to the intraorbital
compartment through the perioptic SAS.8,11 This results in
distension of the ON sheaths and stasis of axoplasmic flow
resulting in axonal swelling and visible disc edema.8,12
Elevated intrasheath pressure is thought to cause the subarachnoid compartment to exert an anterior force that indents the posterior sclera resulting in posterior globe flattening, redundancy and folding of the choroid, and axial
shortening. The disc edema, posterior globe flattening, choroidal folds, and hyperopic shift seen in cases 2, 4, 6, and 7
seem to be consistent with this description. Case 4 is particularly demonstrative (Fig 8). Additionally, we measured
elevated LP opening pressures of 28.5 and 28 cm H2O at 57
days and 12 days, respectively, after returning to Earth.
Although these opening pressures were only mildly elevated, they could represent the downslope of a pressure
spike that may have existed during microgravity exposure.
The specific mechanism of an IIH-like syndrome in
extended microgravity may involve a rise in cephalad ve-
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Figure 8. Postflight axial T2 (3T magnetic resonance imaging) showing
the flattening of the posterior aspect of the right globe (small arrows) and
papilledema (central large arrow) consistent with the optic nerve photography and optical coherence tomography data. Note the marked distension
of the optic nerve sheath, which is consistent with congestion seen at the
level of the optic disc.

nous pressure brought about by microgravity fluid shifts.
Head-down and microgravity studies document that cerebral arterial diameter and blood flow velocity are autoregulated and do not change significantly during space
flight.14,15 In contrast, microgravity fluid shifts are welldocumented to cause jugular vein distension,16 –19 which
suggests that cerebral venous congestion may be present in
the microgravity environment. The classical view of ICP
regulation assumes that CSF is largely produced in the
choroid plexus and drainage depends on the pressure difference between the CSF and the venous system.20 –22 In
this scenario, venous stasis in the head and neck, produced
by cephalad fluid shifts, may cause an impairment of CSF
outflow as well as cerebral venous congestion, both of
which would presumably lead to a rise in ICP.23 An alternate hypothesis suggests that CSF formation and absorption
are due to a balance between hyperosmolar plasma in high
pressure capillaries, and the subsequent absorption of the
formed hypo-osmolar interstitial fluid by the low-pressure
venules that are in anatomic proximity to the high-pressure
capillaries.24 According to this hypothesis, CSF is permanently produced and absorbed in the entire CSF system. If
this is true, the microgravity environment may cause interstitial venous stasis at the level of low pressure CSF venules
and a subsequent decrease in the osmotic drive toward
absorption, resulting in increased ICP. Regardless of the
specific mechanism, perhaps in some anatomically predisposed astronauts, increased venous congestion causes a rise
in CSF pressure of sufficient magnitude to produce the
changes described.
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There are significant arguments against increased ICP
being the sole etiology in the cases we describe. Although
we documented only 2 cases with a clearly elevated LP
opening pressure, our findings in 2 additional patients of
disc edema, ON sheath thickening, and posterior globe
flattening are suggestive of a rise in ICP. However, several
factors may speak against a rise in ICP as a universal cause
of all such findings in the astronaut population. First, this
supposition is largely based on the similarity of our astronaut’s fundi to those of IIH patients observed in a terrestrial
setting. However, the disease process of these IIH patients
arose on Earth, where microgravity and cephalad fluid shifts
played no role in the creation of disc edema, so the specific
etiology cannot be determined on the basis of fundus examination alone. Second, none of our patients with disc
edema, globe flattening, choroidal folds, or hyperopic shifts
presented with chronic headaches, diplopia, transient visual
obscurations, pulse-synchronous tinnitus, or other clinical
symptoms suggestive of elevated ICP. Headache is experienced by ⬎90% of IIH patients, transient visual obscurations in 68%, and sixth nerve palsy in 30%.4,25 This consistent lack of symptoms would be unusual with an ICP of
sufficient magnitude to produce clinically recognizable disc
edema. Third, because no LP was performed in the ISS
during the missions, we have no direct confirmatory evidence that a rise in ICP ever existed during space flight.
Fourth, the prominent degree of globe flattening, disc
edema, widened ON sheaths, and choroidal folds documented in these astronauts are clearly out of proportion to
the relatively unimpressive ICP measurements. Therefore,
etiologies other than a rise in ICP should be considered.
The second possible explanation of our findings is that
the ON head edema is the result of localized events occurring at the level of the intraorbital ON without a rise in CSF
pressure. It has generally been assumed that there is homogeneity of pressure and CSF component concentrations
throughout the SAS of the ONs.26 However, impaired exchange of fluid between the intracranial CSF and that in the
SAS of the ON has been proposed as a possible mechanism
to explain persistent papilledema and visual loss in patients
with IIH despite a functioning lumboperitoneal shunt.27–29
As mentioned, a new hypothesis suggests that CSF is permanently produced and absorbed in the entire CSF system
as a consequence of filtration and reabsorption of water
volume through the capillary walls into the surrounding
brain tissue.24 This implies that the CSF exchange between each portion of the CSF system and the surrounding tissue may depend on pathophysiologic conditions
that predominate within those compartments.24 Also, animal studies document lymphatic drainage of CSF via the
ethmoidal lymphatics.30 Lymphatics in the dura of the
human ON have also been proposed as a CSF outflow
pathway.27 If such lymphatic drainage systems exist,
perhaps microgravity exposure leads to lymph stasis,
which could also be a contributing factor for an increase
in ON sheath pressures. The unique cul de sac–like
anatomic connection between the intracranial SAS and
the SAS of the ON may also create an environment that
could be impacted by microgravity fluid changes. As
noted by Killer et al,27 it is difficult to explain the
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Figure 13. (Top) Preflight images of the right and left optic discs. (Bottom) Postflight images of the optic nerve head showing in more detail the extent
of the edematous optic disc margins and glutting of the superior and inferior nerve fiber layer axons OD and OS (arrows). OD ⫽ right eye; OS ⫽ left
eye.

hydrodynamics of how cranial CSF that enters the SAS of
the ON would change its direction of flow against an
intracranial volume gradient to exit the ON sheath. This
analysis suggests a rather fragile flow equilibrium within
the ON sheath, even in normal subjects. It is self-evident
that under normal 1-G physiologic conditions, CSF secretion, flow, and absorption within the ON sheath are
balanced. Regardless of the specific origin of CSF production and drainage, long-standing microgravity fluid

shifts may bring about alterations in CSF flow dynamics
in the intraorbital portion of the SAS, such that CSF
enters SAS, but outflow may be slightly impeded. Thus,
under prolonged microgravity conditions, CSF in the
SAS of the ON may gradually become partially or completely sequestered, producing a type of ON compartment
syndrome that may result in varying degrees of disc
edema and/or globe flattening, even in the absence of
elevated ICP.

Figure 14. Postflight at ‘return to Earth ⫹39 days’ (R⫹39) red-free fundus photography highlighting the extent of the horizontal choroidal and retinal
folds in the posterior fundus (OD⬎OS). OD ⫽ right eye, OS ⫽ left eye.
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Figure 15. (Top) Preflight (left) and postflight (right) Cirrus spectral domain optical coherence tomography (SD-OCT) of the peripapillary nerve fiber
layer (NFL) thickness maps and ‘TSNIT’ thickness graph for the right and left eyes. An ⬃50-micron thickness increase at the peak of the superior and
inferior NFL poles. (Bottom) Preflight and postflight Cirrus SD-OCT vertical high-definition raster scan through the macula of the right eye showing the
choroidal/retinal folds (arrows). INF ⫽ inferior; NAS ⫽ nasal; OD ⫽ right eye; OS ⫽ left eye; TEMP ⫽ temporal; SUP ⫽ superior; TSNIT ⫽ temporal,
superior, nasal, inferior, temporal (NFL sections).

A third possible etiology for our findings is ocular hypotony. It is well established that there is an initial spike in
intraocular pressure (IOP) on exposure to microgravity followed by a decrease in IOP over a period of days.31 Unfortunately, no long-term studies of IOP have ever been done
in microgravity to document further trends. Head-down bed
rest studies suggest that the initial spike in IOP is followed
by a leveling32 or lowering33,34 of IOP over a period of
days. The initial spike in IOP is thought to occur as a result
of choroidal expansion brought about by cephalad fluid
shifts.32,35 It is hypothesized that the decrease in IOP after
the initial spike may be the result of a compensatory decrease in aqueous volume.32 Although no long-term IOP
data exists from space flight, a low IOP on Earth immediately after space missions has been documented as far back
as the Apollo Program.36 Thus, in-flight, postflight, and
head-down studies suggest the possibility that a lowering of
IOP may occur during extended microgravity exposure.
Although the degree of IOP change is unknown, perhaps in
some individuals the IOP can decrease to the point where
pathologic changes become evident. Ocular hypotony, generally defined as an IOP of ⬍6.5 mmHg, is welldocumented to cause disc edema, posterior globe flattening,
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choroidal folds, and a hyperopic shift very similar to some
of our observed changes.37,38
The etiology of the hyperopic shift, more commonly
observed during extended microgravity exposure, has been
touched on but merits further discussion. In postflight questionnaires completed by approximately 300 NASA astronauts, nearly 50% of astronauts on long-duration ISS missions and 23% on short-duration shuttle missions have
complained of degradation in near vision. A postflight refraction change (i.e., hyperopic shift) was documented in
11% and 34% of astronauts after short and long-duration
missions, respectively (Table 2). This is more clinically
apparent in older astronauts with decreased accommodation. In fact, NASA astronauts over the age of 40 are
routinely offered the use of plus lens “Space Anticipation
Glasses” preflight should they experience a hyperopic shift
during the mission. As noted, this shift is usually reported
after weeks or months in space and less often during short
flights. The onset of the hyperopic shift seems to be gradual,
variable in magnitude, and has been reported to persist in
the 1-G environment for months to years after return to
Earth. Although 1 long-duration, head-down study documented a decrease in near visual acuity after 4 to 5 days of
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head-down tilt,39 another similar study noted no visual
changes.40 Several hypotheses may be offered to explain
this hyperopic shift. In theory, variable increases in ICP
with resultant increases in subarachnoid pressure could
cause corresponding degrees of posterior globe flattening.
We have no data to suggest that disc edema and globe
flattening are common findings in astronauts. The normal
aging process in those ⬎40 may lead to a progressive
shortening of the axial length that could theoretically account for these changes.41 It would be difficult to explain
why this process would be exacerbated by exposure to
microgravity. Changes in corneal refractive power after
exposure to changes in atmospheric pressure and oxygen
partial pressure could be a possible mechanism. However,
considerable research has proven that normal, nonrefractive
surgery corneas are not subject to refractive changes during
exposure to changing environmental conditions.42– 44 It is
also possible, although unlikely, that the fluid shifts within
the eye could result in lenticular changes, which may lead to
alterations in refractive error.
Choroidal expansion may thus at least partially account
for the hyperopic shifts we describe. The spongy, highly
vascular choroid is normally approximately 0.3 mm in
thickness, is drained by the vortex veins, and is likely
sensitive to impeded outflow produced by microgravity.
Perhaps not all of the hyperopic shifts we describe were
caused by indentation of the globe from an elevated subarachnoid pressure but occurred through a different mechanism. Choroidal volume changes in microgravity may be
responsible for the abrupt increase in IOP (within 30 seconds) in orbital and KC-135 parabolic flights as well as
head-down studies.31,32,35 Because ocular liquids within the
eye are incompressible, the IOP depends on the intraocular
fluid volume and the rather rigid elastic properties of the
cornea and sclera. Therefore, a bolus of blood introduced
into the eye will initially cause a rise in IOP.45 Although
increased episcleral venous pressure and orbital congestion
may add to the rise in IOP during microgravity exposure, it
would not explain the sudden IOP increase.32 It is hypothesized that cephalad fluid shifts cause venous congestion in
the neck and head that lead to a rise in vortex vein pressure.32,35 This may cause decreased choroidal drainage and
lead to a relatively stagnant pooling of blood in the choroid.46 This process could result in a small but abrupt
increase in choroidal volume and may account for the
sudden rise in IOP noted during microgravity exposure. The
wide spectrum of degree of hyperopic shift would imply
that there is some variation in the choroidal anatomy and
some are more susceptible to choroidal swelling than others.
Choroidal vasculature alterations have been reported in
highly myopic eyes47 but could also exist in the general
population. Choroidal engorgement over time may push the
macula forward slightly, thus shortening the distance between the macula and the lens. A 0.33-mm anterior displacement at the macula would lead to a 1-D shift toward
hyperopia. This choroidal pooling may gradually expand
the delicate collagen lamella of the choroid beyond its
normal anatomic structural boundaries such that the choroid
becomes permanently distended even on return to the 1-G
environment and in the presence of normal venous back-

pressure. Our case 1, wherein the choroidal folds were
well-documented to be present several years after the mission with no evidence of disc edema, may demonstrate this
point. Choroidal folds have also been documented to exist
for years on Earth in the absence of increased ICP.7 Therefore, in a space traveler there might not be a fixed distance
between the retina and the lens, as there is on Earth. As seen
in Table 2, data from postflight questionnaires completed by
approximately 300 astronauts after their short- and longduration space missions showed that approximately 23% of
the short-duration and 48% of the long-duration mission
astronauts complained of near vision difficulties. It may be
that choroidal expansion and presumably a commensurate
hyperopic shift may be quite common during space flight
and may exist for months to years after return to Earth.
Although a degree of choroidal expansion is likely present in any space traveler some individuals may be anatomically predisposed to the formation of visible choroidal
folds. Choroidal folds may be produced by the mechanical
indentation of the posterior globe from a rise in subarachnoid pressure. Newell48 hypothesized that visible choroid
folds may occur as a result of a combination of variable
anatomic attachments of the choroid to Bruch’s membrane
and some factor that causes congestion in the choriocapillaris. When choroidal expansion occurs and this attachment
is not present, the pigment epithelium slips easily over the
choriocapillaris, the folds are not produced, and the fundus
has a smooth appearance despite choroidal thickening. Alternatively, choroidal congestion combined with adhesions
prevents this slipping and leads to the classic striations of
choroidal folds. The light lines, seen in ophthalmoscopy,
correspond to the crests of the folds where the retinal
pigment epithelium is attenuated. The dark lines correspond
with the troughs of the folds where there is compaction of
the retinal pigment epithelium. Thus, choroidal expansion
may have a different clinical appearance depending on the
microanatomy of the individual astronaut. Although prominent choroidal expansion is rather unusual on Earth, our
report suggests that it may be common on exposure to
extended microgravity. Therefore, the hyperopic shifts observed in these astronauts may not universally result from a
rise in ICP or a drop in IOP. However, they may be the
consequence of local fluid changes within the eye and orbit
brought about by microgravity exposure.
We also report unilateral CWS in 3 astronauts after
exposure to extended microgravity. Only one occurred in
conjunction with ON edema in that eye. Feathery edged
infarctions of the surface of the NFL layer, CWS usually
occur in the area of the radial peripapillary capillaries.49
They are thought to be accumulations of cytoplasmic debris
caused by focal obstruction of orthograde and or retrograde
axoplasmic transport29 and they may leave a permanent
retinal defect.50 The fundamental lesion causing a CWS is
thought to be precapillary arteriolar closure.50,51 Although
CWS are nonspecific, they are well known to occur in
diabetes mellitus,52 HIV retinopathy,53 Purtscher’s retinopathy,54 high-altitude retinopathy,55 and hypertensive retinopathy.56 They are not commonly associated with increased ICP. The etiology of these findings in our astronauts
is unknown, but we may assume that these changes are

2067

Ophthalmology Volume 118, Number 10, October 2011
somehow related to cephalad fluid shifts during extended
space flight. As noted, local, asymmetric microgravity related changes in CSF flow within the intraorbital portion of
the ON may lead to a biochemically altered CSF that may
cause a metabolic toxicity to the ON and set the stage for
focal arteriolar closure. A similar hypothesis has been previously proposed as a mechanism for other forms of axoplasmic stasis.29
In summary, although a definitive etiology is unknown,
we hypothesize that venous congestion in the brain and/or
eye, brought about by cephalad fluid shifts and perhaps
exacerbated by choroidal volume changes, may be a unifying pathologic mechanism to explain our findings. These
findings may occur in conjunction with microgravityinduced CSF flow disturbances within the ON sheath. Regardless of specific etiology, the disc edema, globe flattening, choroidal folds, and hyperopic shifts we report may
represent parts of a spectrum of ocular and cerebral response to microgravity. Because all symptoms occurred
after long-term exposure to microgravity and the disc edema
in 2 astronauts was documented by direct observation on
board the spacecraft, it would be extremely unlikely that the
effects of takeoff, reentry, or landing were involved. Because detailed preflight and postflight dilated retinal examinations with fundus photography and OCT have only been
conducted in NASA astronauts over the last 4 years and all
cases we report were largely asymptomatic, this suggests
that similar cases may have been missed in the past. Recently, NASA has initiated a protocol to acquire prospective
preflight, in-flight, and postflight data on all future astronauts to define the exact origin of these potentially harmful
ocular changes. These data would include preflight and
postflight MRI, OCT, and LPs when appropriate, as well as
preflight, in-flight, and postflight IOP measurement, dilated
eye examination, ultrasound imaging, cycloplegic refraction, and fundus photography.
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Fig. 1; [Top group; upper row] Preflight fundus images of the right and left
posterior pole. [Top group; lower row] Postflight return to Earth + 19 days
(R+19) images of the right and left posterior pole showing choroidal folds
below the optic disc (top arrow) and a “cotton-wool” spot (bottom arrow)
in the inferior arcade of the right eye. Optic disc imaging did not show
presence of observable disc edema.
[Bottom group] Postflight return to Earth + greater than 5 year (R+ >5
years) spectral domain optical coherence tomography (SD-OCT) images
showing the presence and persistence of the choroidal folds (arrows)
inferior to the right optic disc. Choroidal folds are now only detectable
with SD-OCT. OD=right eye, OS=left eye.

